PDS Biotechnology Corp - Common (PDSB)

Historical Holders from Q1 2019 to Q4 2025

Type / Class
Equity / Common
Symbol
PDSB on Nasdaq
Shares outstanding
49,594,356
Price per share
$0.7698
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
5,620,337
Total reported value
$6,638,921
% of total 13F portfolios
0%
Share change
-1,817,614
Value change
-$1,895,965
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
47
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, PDS Biotechnology Corp - Common (PDSB) has 47 institutional shareholders filing 13F forms. They hold 5,620,337 shares of 49,594,356 outstanding shares (11%) .

Top 25 institutional shareholders own 11% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 3.8% 1,901,441 -2.6% 0% $1,920,455
BlackRock, Inc. 1% 517,519 +0.61% 0% $522,694
GEODE CAPITAL MANAGEMENT, LLC 0.97% 481,999 +15% 0% $486,906
CITADEL ADVISORS LLC 0.78% 386,430 +55% 0% $390,294
INSPIRION WEALTH ADVISORS, LLC 0.69% 344,394 +339% 0.18% $1,315,585
Squarepoint Ops LLC 0.59% 291,627 +198% 0% $294,543
RENAISSANCE TECHNOLOGIES LLC 0.56% 275,861 +161% 0% $278,620
BLAIR WILLIAM & CO/IL 0.5% 250,000 0% 0% $252,500
UBS Group AG 0.4% 200,236 -63% 0% $202,238
STATE STREET CORP 0.27% 133,333 0% 0% $134,666
NORTHERN TRUST CORP 0.23% 113,472 -7.2% 0% $114,607
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.19% 94,344 +604% 0% $95,287
COMMONWEALTH EQUITY SERVICES, LLC 0.18% 90,497 -0.19% 0% $91,000
Iron Gate Global Advisors LLC 0.15% 75,016 0.01% $76,516
ACADIAN ASSET MANAGEMENT LLC 0.12% 61,793 0% $61,000
Watts Gwilliam & Co., LLC 0.11% 55,000 0% 0.01% $55,550
Tempus Wealth Planning, LLC 0.1% 47,800 0% 0.01% $48,278
JANE STREET GROUP, LLC 0.07% 36,581 -47% 0% $36,947
Rockefeller Capital Management L.P. 0.07% 34,467 0% $34,812
Bank of New York Mellon Corp 0.06% 29,293 0% 0% $29,586
XTX Topco Ltd 0.04% 19,699 0% $19,896
Federation des caisses Desjardins du Quebec 0.04% 18,800 0% 0% $18,988
DIMENSIONAL FUND ADVISORS LP 0.04% 18,382 0% 0% $18,566
FIRST MANHATTAN CO. LLC. 0.03% 15,000 0% 0% $15,150
TWO SIGMA SECURITIES, LLC 0.03% 14,149 -37% 0% $14,290

Institutional Holders of PDS Biotechnology Corp - Common (PDSB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 180,495 $138,945 -$126,169 $0.7698 1
2025 Q3 5,620,337 $6,638,921 -$1,895,965 $1.01 47
2025 Q2 7,451,352 $9,901,943 -$1,043,791 $1.33 55
2025 Q1 8,226,452 $9,789,276 +$4,484,828 $1.19 46
2024 Q4 4,239,917 $6,914,602 -$572,034 $1.63 51
2024 Q3 4,325,988 $16,519,540 -$3,544,953 $3.82 56
2024 Q2 5,489,394 $16,083,121 -$6,957,012 $2.93 73
2024 Q1 7,611,671 $30,140,536 -$4,107,493 $3.96 69
2023 Q4 8,335,087 $41,487,859 +$2,355,421 $4.97 74
2023 Q3 7,861,668 $39,699,832 -$403,816 $5.05 78
2023 Q2 7,931,948 $39,898,006 -$317,214 $5.03 80
2023 Q1 7,611,967 $46,811,436 +$1,184,438 $6.15 66
2022 Q4 6,820,799 $90,031,703 +$24,029,740 $13.20 63
2022 Q3 5,178,399 $15,378,000 -$458,535 $2.97 42
2022 Q2 5,251,472 $19,171,000 -$3,835,298 $3.65 46
2022 Q1 5,851,637 $36,220,000 -$1,228,374 $6.19 49
2021 Q4 5,916,212 $47,919,000 -$12,229,786 $8.10 63
2021 Q3 6,752,518 $100,597,635 +$11,330,602 $14.90 58
2021 Q2 5,941,843 $74,429,183 +$40,638,979 $12.55 41
2021 Q1 3,145,310 $14,311,158 +$1,348,464 $4.55 29
2020 Q4 3,132,654 $6,703,955 -$487,455 $2.14 25
2020 Q3 3,298,108 $7,682,631 +$3,730,298 $2.33 27
2020 Q2 1,702,221 $3,419,000 +$619,479 $2.01 18
2020 Q1 1,628,998 $1,184,000 +$761,576 $0.7250 19
2019 Q4 539,706 $1,429,005 +$70,841 $2.65 15
2019 Q3 509,321 $1,716,054 +$122,431 $3.37 16
2019 Q2 460,755 $2,759,096 +$1,030,776 $5.99 16
2019 Q1 287,260 $2,124,000 +$2,124,000 $7.39 13